Mary K. Moreland is President & VP at ABBOTT LABORATORIES (ABT). They have made 8 open-market trades across 1 company since 2020, most recently 2026-03-02.
CIK 0001783147
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABT | 104,291 | $12.1M |
Shares reported on the most recent Form 4, priced at the 2026-03-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2026-03-02 | 2026-03-03 | $115.58 | $71K | -4.9% | -9.5% | -22.8% |
| ABT | SELL | 2025-03-03 | 2025-03-04 | $138.17 | $219K | -7.4% | -3.8% | -2.4% |
| ABT | SELL | 2024-03-01 | 2024-03-04 | $118.50 | $80K | -1.3% | -7.6% | -14.6% |
| ABT | SELL | 2023-03-01 | 2023-03-02 | $100.77 | $145K | -4.2% | -1.3% | -0.9% |
| ABT | SELL · 10b5-1 | 2021-02-22 | 2022-02-23 | $119.31 | $48K | +3.4% | +3.4% | -1.1% |
| ABT | SELL | 2021-02-22 | 2021-02-23 | $121.84 | $49K | -2.9% | -1.4% | -2.9% |
| ABT | SELL | 2021-02-16 | 2021-02-18 | $128.49 | $130K | -2.2% | -3.0% | -7.1% |
| ABT | SELL | 2020-02-25 | 2020-02-25 | $84.93 | $34K | -0.5% | -7.7% | +8.9% |
| ABT | SELL | 2020-02-19 | 2020-02-19 | $88.97 | $181K | -8.4% | -23.7% | -1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.